Navigation Links
Optimizing the Use of Health Outcomes Data in the Marketplace
Date:9/21/2011

CHAPEL HILL, N.C., Sept. 21, 2011 /PRNewswire/ -- Pharmaceutical and biotechnology organizations use health outcomes data to support a variety of product-related initiatives, from treatment guidelines to formulary decisions. With health outcomes data playing such a pivotal role in a product's performance, it's important for organizations to optimize the use of Health Outcomes data.

To help organizations understand current approaches to effectively using health outcomes data in the marketplace, Best Practices, LLC has published a study that examines the internal and external uses of Health Outcomes data for promotional and strategic purposes.

The study, Best Practices in Utilizing Health Outcomes Data, provides comparative data from 2009 and 2011 that illustrate shifting attitudes for how organizations utilize health outcomes data.

Organizations in 2011 used health outcomes data internally mostly for determining market access and scientific publication strategies. Relative to 2009, the importance of using health outcomes data internally for reimbursement decisions increased 24 percent, from 45 percent in 2009 to 69 percent in 2011, according to the study. Meanwhile, in 2011 and 2009, reimbursement and drug formulary decisions were the main use of health outcomes data for interactions with managed care, according to the study.

The 51-page study reflects current approaches to health outcomes data utilization at 16 biopharma organizations; the 2009 data is based on a benchmark class of 29 companies.

The insights in this new study will help pharmaceutical and biotech organizations compare their use of health outcomes data in promotional and internal settings with that of leading organizations. The study also examines the pressing regulatory issues raised by the different uses of health outcomes data.

Key topics covered in this research include:

    '/>"/>

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients
2. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
3. Opportunities in Emerging Pharma Markets: Strategies for Optimizing Growth in Key Regions and Therapeutic Areas
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Health Strategies Group Introduces New One-Stop Suite of Intelligence Services for Optimizing Marketing and Sales Resources in the Institutional Channel
6. Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
7. RadMD Offers Tips on Optimizing Clinical Trial Efficiency
8. At Home Healthcare Expands Telehealth Program With Cardiocom® Telehealth Technology
9. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
10. Genomic Health to Present at the JMP Securities Healthcare Conference
11. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... for Advanced Drug Delivery Systems -- Focus ... STUDY OBJECTIVES ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
... results, SAN DIEGO, April 9, 2008 ... Meeting suggest that an all-natural dietary,supplement made from ... lower,their blood glucose numbers after a meal and ... PhD, KGK Synergize Inc.,s Scientific Director,said, "Our scientifically ...
... Calif., April 9, 2008 ,Sunesis Pharmaceuticals, Inc. (Nasdaq: ... present data on each of its clinical-stage anticancer,compounds ... Association for,Cancer Research (AACR) being held April 12-16 ... of product candidates in oncology focused on novel,pathways ...
Cached Medicine Technology:People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 2People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 3Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research 2Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research 3
(Date:4/18/2014)... (April 21, 2014) -- A group of scientists ... and the Sanders-Brown Center on Aging has found ... and neuropsychological function in Parkinson,s disease (PD). ... , the study, which assessed cognitive function in ... the dopamine replacement therapy commonly used to treat ...
(Date:4/18/2014)... The Gerontologist reports that among ... a decrease in anxiety about death and increases in ... lives. In particular, listening to gospel music is associated ... increase in sense of control. , These associations are ... individuals of both low- and high-socioeconomic status. , The ...
(Date:4/18/2014)... have been awarded two-year grants for their work on ... Of the 110 initial submissions to the new Novo ... four projects were funded, three of which are led ... Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, M.D., ... will use his $500,000 proof of principle grant to ...
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at ... how blocking a particular molecule in metastatic breast cancer ... number of lung metastases. BRI scientists have found in ... shrink tumors by 60 - 80 percent and can ... lung. The $1.8 million five-year grant comes from the ...
(Date:4/18/2014)... new study in the American Journal of Preventive ... reveals a recurring pattern that could be leveraged to ... San Diego State University, the Santa Fe Institute, Johns ... searches (searches that included the term healthy and were ... from 2005 to 2012. They found that on average, ...
Breaking Medicine News(10 mins):Health News:Treating depression in PD patients: New research 2Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New research shows people are thinking about their health early in the week 2
... a link may exist between radon exposure and non-melanoma skin ... Human Health (part of the Peninsula College of Medicine & ... radon exposure and skin cancer cases from across southwest England. ... and Cornwall, builds upon a similar study conducted 15 years ...
... difference in the outcome for patients who received carotid artery ... (TIA) or stroke versus those who received CAS at 30 ... the removal of plaque from the carotid artery take place ... best outcomes. However, little is known about the optimal timing ...
... , MONDAY, Nov. 14 (HealthDay News) -- ... to greatly increase the risk of Parkinson,s disease, and ... of developing the neurodegenerative disorder, a new study indicates. ... States have Parkinson,s disease and more than 50,000 new ...
... to research linking alcohol to breast cancer risk, a new ... shows that adolescent girls with a family history of breast ... become cancer have a higher risk of developing benign ... girls without a family history, this already-elevated risk rises with ...
... News) -- Patients who develop atrial fibrillation -- a ... they are hospitalized with severe sepsis are at increased ... Atrial fibrillation (AF) is one of the most ... to background study information. Six percent to 20 percent ...
... , SUNDAY, Nov. 13 (HealthDay News) -- People who ... lower their risk for heart attack or stroke, new research ... the American Heart Association,s annual meeting, in Orlando, Fla. ... heart problems or stroke for an average of seven years, ...
Cached Medicine News:Health News:Suggested link between radon and skin cancer 2Health News:Impact of timing on carotid artery stenting after stroke or transient ischemic attack 2Health News:Exposure to Toxic Solvents Linked to Parkinson's Disease 2Health News:Girls with family history of breast disease should avoid alcohol 2Health News:Girls with family history of breast disease should avoid alcohol 3Health News:Sepsis Plus Heart Rhythm Disorder Linked to Stroke, Death 2Health News:Regular Teeth Cleanings Could Cut Heart Attack Risk: Study 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: